Teladoc Health, Inc. · NYSE:TDOC
Teladoc Health — Credit Suisse 28th Annual Healthcare Conference 2019
14 slides from Teladoc Health's conference presentation, Nov 12, 2019
Slide 1: Credit Suisse 28th Annual Healthcare Conference
Credit Suisse 28th Annual Healthcare Conference November 12
Slide 2: Safe harbor
Safe harbor + This presentation contains, and our officers may make, “forward-looking” statements that are based on our management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning poss
Slide 3: Transforming how people access healthcare around the world
At Teladoc Health, we are transforming how people access healthcare around the world. We are creating a new kind of healthcare experience – one with greater convenience, outcomes, and value.
Slide 4: Teladoc Health at a glance
TDOC +2,200 +50,000 +3,000 ~10 million publicly-traded employees experts across network cumulative visits on NYSE since 2015 worldwide 450+ specialties clinicians through YE 2019
Slide 5: Quarter highlights
• ✓ ✓ ✓ • ✓ Over 17 million people added to the platform during the quarter, including 15 million with UnitedHealthcare. • ✓ Over 50% y/y growth in visits. ✓ BetterHelp surpassed the 50 million message milestone. ✓ Launched United Kingdom’s first virtual Mental Health Service for complex conditions.
Slide 6: Revenue and visit growth, gross margin
65% 61% Revenue CAGR Visit CAGR (2016-2019E) (2016-2019E) 106% 79% 66% 35.0 mm 19.0 mm 39% US paid access US visit fee 34% 28% membership only lives Q3 2019 Q3 2019 69% Gross margin Q3 2019 (1) Full-year and quarter management guidance; midpoint of range, unless otherwise noted.
Slide 7: Global reach, entrenched distribution, science and results
Engagement Global Reach Science & Results Entrenched Tech-Enabled Ops at Distribution Across Category-defining brand Market leadership Consumer demand Premium pricing Scale Channels Returns to scale Proven ROI Product/Clinical Proprietary Clinical Scope of Offerings Capabilities
Slide 8: Distribution channels, products and services, growth levers
Distribution Channels International markets Expand footprint & Hospitals & Health Systems distribution DTC Insurers Clinical services Employers innovation Products & Services Growth levers Accelerate Telemedicine New distribution consumer adoption Virtual COE specialty services Penetration of existi
Slide 9: Center of Excellence and urgent care
Center of Excellence Multi- Urgent specialty Care clinic
Slide 10: Measures of Success
Measures of Success Teladoc. HEALTH © 2002-2019 Teladoc Health, Inc. All rights reserved,
Slide 11: Strong demand across all channels
Strong demand across all channels RFP pipeline up ~25% Bookings up ~30% Larger average deal size Multi-product represents half of year-to-date bookings
Slide 12: Paid membership net adds and PMPM
Q3 FY Paid Membership Net Adds (millions) PMPM Organic onboarding of large health plan populations 7.8% 8.0% Acquisition of Advance Medical $0.98 6.8% 6.6% Acquisition of Best Doctors + 8.1 4.7% 5.0% + 3.9 + 3.9 + 2.7 + 1.5 + 1.7 + 1.0 + 1.2 + 0.7 + 0.4 + 0.5 + 0.3 + 0.3 + 0.3 + 0.2 + 0.1 + 0.2 + 0.
Slide 13: ~10 million cumulative visits by YE 2019
~10 million cumulative visits by YE 2019
Slide 14: Teladoc Health: compelling financial model
Teladoc Health: compelling financial model ¢ Multiple vectors driving sustainable top-line growth in a large addressable global market * High degree of visibility into future revenue streams « Scalable model ¢ Approach to growth: build, buy and partner * Strong & flexible balance sheet - $491 millio
Teladoc Health — Credit Suisse 28th Annual Healthcare Conference 2019 on 6ix